Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

This study is currently recruiting participants.

Verified by Stanford University, July 2008

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00568438

Purpose

The goal of this study is to study NIS expression in benign and malignant breast and thyroid samples using archival formalin-fixed paraffin-embedded tissue sections.

Condition
Breast Cancer Stomach Neoplasms Salivary Gland Neoplasms Thyroid Cancer

Genetics Home Reference related topics: breast cancer

MedlinePlus related topics: Breast Cancer Cancer Salivary Gland Disorders Stomach Cancer Thyroid Cancer

U.S. FDA Resources

Study Type:	Observational
Official Title:	Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival and Frozen Human Tissue Samples

Further study details as provided by Stanford University:

Estimated Enrollment:	300
Study Start Date:	October 2000

Detailed Description:

The objective of the study is to further understanding of proteins that occur in both normal cells and tumor cells and to learn more about certain diseases and potential alternative treatments for these diseases.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:Subject is scheduled to have a biopsy or operation for clinical purposes or are able to provide a fluid (e.g. breast milk or cyst fluid).

Subject agrees to have tissue tested.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00568438

Locations

United States, California
Stanford University School of Medicine	Recruiting
Stanford, California, United States, 94305
Contact: Marilyn Florero 650-724-1953 florerom@stanford.edu
Contact: Cancer Clinical Trials Office (650) 498-7061
Principal Investigator: Irene L. Wapnir
Sub-Investigator: Ralph S. Greco MD
Sub-Investigator: Kent W Nowels

Sponsors and Collaborators

Stanford University

Investigators

Principal Investigator:

Irene L. Wapnir

Stanford University

More Information

Study ID Numbers:	SU-11082007-856, 75622, BRSNSTU0011, NCT00568438
Study First Received:	December 4, 2007
Last Updated:	July 2, 2008
ClinicalTrials.gov Identifier:	NCT00568438
Health Authority:	United States: Food and Drug Administration; United States: Institutional Review Board

Study placed in the following topic categories:

Mouth Diseases
Digestive System Neoplasms
Thyroid Neoplasms
Skin Diseases
Gastrointestinal Diseases
Breast Neoplasms
Endocrine System Diseases
Stomach cancer
Mouth Neoplasms
Salivary Gland Neoplasms
Stomach Diseases

Digestive System Diseases
Oral cancer
Stomach Neoplasms
Head and Neck Neoplasms
Gastrointestinal Neoplasms
Endocrinopathy
Stomatognathic Diseases
Salivary Gland Diseases
Breast Diseases
Thyroid Diseases
Endocrine Gland Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 15, 2009